Catalyst Wire Dossier Catalyst Wire Dossier

Biosimilar lispro (unnamed in snippet)

insulin lispro · Gan and Lee Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Biosimilar lispro (unnamed in snippet), covering 2020-02-05 to 2020-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Gan & Lee Evaluation of New Biosimilar for Type 1 Lispro [Phase 3]

See pricing